Aktionsplan Allurion Technologies, Inc.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen Allurion Technologies, Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.| IPO date | 2023-08-02 |
|---|---|
| ISIN | US02008G1022 |
| Industry | Diversified Consumer Services |
| Sector | Consumer Discretionary |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.allurion.com |
| Цена ао | 0.7601 |
| Preisänderung pro Tag: | +0.4157% (0.433) |
|---|---|
| Preisänderung pro Woche: | +24.94% (0.348) |
| Preisänderung pro Monat: | +10.08% (0.395) |
| Preisänderung über 3 Monate: | -30.5% (0.6256) |
| Preisänderung über sechs Monate: | -65.49% (1.26) |
| Preisänderung pro Jahr: | -88.37% (3.74) |
| Preisänderung über 3 Jahre: | -96.86% (13.8352) |
| Preisänderung über 5 Jahre: | 0% (0.4348) |
| Preisänderung über 10 Jahre: | 0% (0.4348) |
| Preisänderung seit Jahresbeginn: | +26.76% (0.343) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institutionen | Volumen | Aktie, % |
|---|---|---|
| RTW Investments LP | 3457707 | 7.23 |
| Fortress Investment Group LLC | 1284004 | 2.68 |
| Unisphere Establishment | 1242330 | 2.6 |
| Blackrock Inc. | 489531 | 1.02 |
| Vanguard Group Inc | 465515 | 0.97 |
| Geode Capital Management, LLC | 323604 | 0.68 |
| Northern Trust Corporation | 69619 | 0.15 |
| State Street Corporation | 56914 | 0.12 |
| Sage Rock Capital Management LP | 42000 | 0.09 |
| Accredited Investors | 37500 | 0.08 |
| ETF | Aktie, % | Rentabilität für das Jahr, % | Dividenden, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00169 | 17.09 | 1.54048 |
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Dr. Shantanu K. Gaur M.D. | Co-Founder, CEO, President & Director | 661.23k | 1987 (38 Jahre) |
| Dr. Samuel G. Levy | Co-Founder | N/A | 1983 (42 Jahr) |
| Mr. Christopher Geberth | CFO & Treasurer | 542.59k | 1972 (53 Jahr) |
| Dr. Ram Chuttani M.D. | MD, Chief Medical Officer & Founding Partner | N/A | 1961 (64 Jahr) |
| Ms. Joyce Johnson | Senior Vice President of Regulatory Affairs & Quality Assurance | N/A | |
| Mr. Brendan Michael Gibbons | Chief Legal Officer & Corporate Secretary | N/A | 1976 (49 Jahre) |
| Mr. Ojas A. Buch | Chief Operating Officer | 1973 (52 Jahr) | |
| Mr. Matt Wright | Vice President of People |
Adresse: United States, Natick. MA, 11 Huron Drive - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.allurion.com
Webseite: https://www.allurion.com
